3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
11
Esophageal Neoplasms
9
Stomach Neoplasms
8
Colorectal Neoplasms
8
Recurrence
7
Rectal Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Sarcoma
6
Uterine Cervical Neoplasms
5
Pancreatic Neoplasms
5
Glioma
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Thyroid Neoplasms
3
Pituitary Neoplasms
3
Pilonidal Sinus
3
Neoplasms
3
Glioblastoma
3
Cholangiocarcinoma
3
COVID-19
3
Vulvar Neoplasms
2
Urinary Bladder Neoplasms
2
Pain, Postoperative
2
Neoplasm Metastasis
2
Melanoma
2
Lymphatic Metastasis
2
Kidney Neoplasms
2
Inflammation
2
Interventions
xiapex
2
Surgical Procedures, Operative
1
Microbial Collagenase
1
Injections, Intra-Articular
1
Fasciotomy
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Knee
1
Arthroplasty, Replacement, Elbow
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Dupuytren Contracture
×
Surgical Procedures, Operative
×
Clear all
NCT01444729
2017-10-26
Post Approval Commitment Study
Endo Pharmaceuticals
Completed
305 enrolled